# NeuroOne Medical Technologies Corporation (NMTC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NMTC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.39M | $ -2.09M | $ -1.37M | $ 207.0K | $ 5.37M |
| 2025 | $ 8.92M | $ -6.99M | $ -6.41M | $ 237.4K | $ 6.40M |
| 2024 | $ 6.04M | $ -7.56M | $ -7.46M | $ 341.5K | $ 2.94M |
| 2023 | $ 3.04M | $ -14.57M | $ -14.72M | $ 153.7K | $ 4.42M |
| 2022 | $ 281.5K | $ -9.97M | $ -9.56M | $ 272.4K | $ 8.17M |
| 2021 | $ 166.9K | $ -12.83M | $ -11.30M | $ 288.4K | $ 15.95M |
| 2020 | $ 2.55M | $ -13.97M | $ -5.37M | $ 298.3K | $ 1.41M |
| 2019 | $ 0 | $ -12.99M | $ -7.73M | $ 5.53M | $ -4.61M |
| 2018 | $ 0 | $ -8.57M | $ -3.87M | $ 2.19M | $ -4.96M |
| 2017 | $ 0 | $ -6.81M | $ -2.84M | $ 2.42M | $ -5.04M |
| 2016 | $ 140 | $ -420.5K | $ -241.8K | $ 275.2K | $ -266.2K |
| 2015 | $ 1.0K | $ -88.3K | $ -42.0K | $ 13.6K | $ -81.5K |
| 2014 | $ 1.1K | $ -51.2K | $ -37.0K | $ 0 | $ -35.4K |
| 2013 | $ 1.8K | $ -43.5K | $ -35.7K | $ 28.0K | $ -30.3K |
| 2012 | $ 1.3K | $ -20.4K | $ -19.8K | $ 17.0K | $ -17.2K |
| 2011 | $ 7.9K | $ -40.6K | $ -40.3K | $ 0 | $ -3.3K |
| 2010 | $ 1.0K | $ -12.9K | $ -8.0K | $ 0 | $ -4.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.46 |
| Current Ratio | 4.37 |

## Other views

- [Metrics](https://sponda.capital/en/NMTC.md)
- [Charts](https://sponda.capital/en/NMTC/charts.md)
- [Compare](https://sponda.capital/en/NMTC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.